Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Downgrades Continental Resources to Market Perform

Raymond James analyst John Freeman downgrades Continental Resources (NYSE:CLR) from Outperform to Market Perform.
byBenzinga Newsdesk
October 24, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst John Freeman downgrades Continental Resources (NYSE:CLR) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Ascendis Pharma Announced Once-Weekly TransCon CNP Achieved Primary Efficacy Objective, with Superiority at 100 µg/kg/week, in Phase 2 ACcomplisH Trial of Children with Achondroplasia Aged 2 to 10 Years

By Charles Gross
November 13, 7:17 PM
Ascendis Pharma A/S (Nasdaq: ASND) today announced positive topline results from the ACcomplisH Trial, its Phase 2 randomized, double-blind, placebo-controlled, dose-escalation trial evaluating the safety and efficacy of once-weekly TransCon CNP compared to placebo in children with achondroplasia aged 2 to 10 years old.

ASND